Open Journal of Gastroenterology

Vol.2 No.2(2012), Paper ID 18318, 4 pages

DOI:10.4236/ojgas.2012.22015

 

Impact of Lamivudine plus Adefovir therapy in chronic hepatitis B Iranian patients, resistant to Lamivudine treatment alone, on disease inhibition: A pilot study

 

Arezoo Estakhri, Ashraf Mohamadkhani, Hosein Poustchi, Ghodrat Montazeri

 

Digestive Disease Research Institute(DDRI) ,Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
Digestive Disease Research Institute(DDRI) ,Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
Digestive Disease Research Institute(DDRI) ,Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
Digestive Disease Research Institute(DDRI) ,Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran

 

Copyright © 2012 Arezoo Estakhri, Ashraf Mohamadkhani, Hosein Poustchi, Ghodrat Montazeri et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


Estakhri, A. , Mohamadkhani, A. , Poustchi, H. and Montazeri, G. (2012) Impact of Lamivudine plus Adefovir therapy in chronic hepatitis B Iranian patients, resistant to Lamivudine treatment alone, on disease inhibition: A pilot study. Open Journal of Gastroenterology, 2, 72-75. doi: 10.4236/ojgas.2012.22015.

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.